​​​​​​ContattiInvestorsCareersMediaScienceContact Us






•    OMS, Statement on the fifteenth meeting of the IHR (2005) Emergency Committee on the COVID-19 pandemic (https://www.who.int/news/item/05-05-2023-statement-on-the-fifteenth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-coronavirus-disease-(covid-19)-pandemic)
•    OMS, XBB.1.16 Initial Risk Assessment, 17 April 2023 (https://www.who.int/docs/default-source/coronaviruse/21042023xbb.1.16ra-v2.pdf?sfvrsn=84577350_1)
•    Centers for Disease Control and Prevention. Underlying medical conditions associated with higher risk for severe COVID: information for healthcare professionals. Updated February 9, 2023. Ultimo accesso 10 maggio 2023. https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/underlyingconditions.html#:~:text=race%20and%20ethnicity.-,Age,U.S.%20COVID-19%20related%20deaths%20 
•    Yanez ND, Weiss NS, Romand JA, Treggiari MM. COVID-19 mortality risk for older men and women. BMC Public Health. 2020 Nov 19;20(1):1742. doi: 10.1186/s12889-020-09826-8. PMID: 33213391; PMCID: PMC7675386.
•    SORVEGLIANZA COVID-19 - epiCentro.iss.it  
•     Cho JL, Villacreses R, Nagpal P, Guo J, Pezzulo AA, Thurman AL, Hamzeh NY, Blount RJ, Fortis S, Hoffman EA, Zabner J, Comellas AP. Quantitative Chest CT Assessment of Small Airways Disease in Post-Acute SARS-CoV-2 Infection. Radiology. 2022 Jul;304(1):185-192. doi: 10.1148/radiol.212170. Epub 2022 Mar 15. PMID: 35289657; PMCID: PMC9270680.
•    Bowe, B., Xie, Y. & Al-Aly, Z. Acute and postacute sequelae associated with SARS-CoV-2 reinfection. Nat Med 28, 2398–2405 (2022). https://doi.org/10.1038/s41591-022-02051-3
•    Flacco ME, Acuti Martellucci C, Baccolini V, De Vito C, Renzi E, Villari P, Manzoli L. COVID-19 vaccines reduce the risk of SARS-CoV-2 reinfection and hospitalization: Meta-analysis. Front Med (Lausanne). 2022 Nov 9;9:1023507. doi: 10.3389/fmed.2022.1023507. PMID: 36438045; PMCID: PMC9681813.
•    Ministero della Salute - Aggiornamento Circolare “Interventi in atto per la gestione della circolazione del SARS-CoV-2 nella stagione invernale 2022-2023” (https://www.trovanorme.salute.gov.it/norme/renderNormsanPdf?anno=2023&codLeg=91260&parte=1%20&serie=null
•    Jennings G, Monaghan A, Xue F, Mockler D, Romero-Ortuño R. A Systematic Review of Persistent Symptoms and Residual Abnormal Functioning following Acute COVID-19: Ongoing Symptomatic Phase vs. Post-COVID-19 Syndrome. J Clin Med. 2021 Dec 16;10(24):5913. doi: 10.3390/jcm10245913. PMID: 34945213; PMCID: PMC8708187.
•    Centers for Disease Control and Prevention. Long COVID or Post-COVID Conditions. Updated Dec. 16, 2022. Ultimo accesso 10 maggio 2023. https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/index.html%C2%A0
•    Lopez-Leon S, Wegman-Ostrosky T, Ayuzo Del Valle NC, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, Villapol S. Long-COVID in children and adolescents: a systematic review and meta-analyses. Sci Rep. 2022 Jun 23;12(1):9950. doi: 10.1038/s41598-022-13495-5. PMID: 35739136; PMCID: PMC9226045.
•    Gao P, Liu J, Liu M. Effect of COVID-19 Vaccines on Reducing the Risk of Long COVID in the Real World: A Systematic Review and Meta-Analysis. Int J Environ Res Public Health. 2022 Sep 29;19(19):12422. doi: 10.3390/ijerph191912422. PMID: 36231717; PMCID: PMC9566528.
•    Chen et al; Global Prevalence of Post-Coronavirus Disease 2019
(COVID-19) Condition or Long COVID: A Meta-Analysis
and Systematic Review. The Journal of Infectious Diseases. 2022:226